Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
about
Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittiiHigh prevalence of bla OXA-23 in Acinetobacter spp. and detection of bla NDM-1 in A. soli in Cuba: report from National Surveillance Program (2010-2012).The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.Identification of NDM-1 in a Putatively Novel Acinetobacter Species ("NB14") Closely Related to Acinetobacter pittii.The Genetic Analysis of an Acinetobacter johnsonii Clinical Strain Evidenced the Presence of Horizontal Genetic Transfer.Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.Therapeutic options for Acinetobacter baumannii infections: an update.The Acinetobacter baumannii group: a systemic review.Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumanniiAcinetobacter lwoffii Peritonitis in a Patient on Automated Peritoneal Dialysis: A Case Report and Review of the Literature.MALDI-TOF MS for the Identification of Cultivable Organic-Degrading Bacteria in Contaminated Groundwater near Unconventional Natural Gas Extraction Sites.First carbapenem-resistant isolates of Acinetobacter soli in Japan.Acinetobacter lwoffii peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.Description of the metallo-β-lactamase GIM-1 in Acinetobacter pittii.Comparison of clinical manifestations and antibiotic resistances among three genospecies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
P2860
Q33798301-F6BC77FC-6948-4D99-AFE3-FA9E9EC29EFDQ35880155-5D00039E-DF9B-45AD-85ED-A9CAEA1058E2Q35905605-2C81C486-56C6-4175-A3F9-4C014FE4F59CQ36006835-5379039A-DBA2-4E76-AE5F-EA013A0A5ACEQ36076032-660A59DE-365E-4253-B31C-1A4CCDA2E2B3Q36109037-69AECD0E-23CB-4542-A7EA-D3F262CB2DFFQ36364023-30D72EAB-D8EA-4191-BDE6-6E1AE42D125FQ37544621-852922D0-C1C7-46CE-B8AB-2CBF25FF9D04Q38049332-280BD336-482B-4B41-BBAB-BEFFF1B0EC64Q38248609-05A3927A-93DB-42C2-BDD4-73E8E87615AEQ39063044-48D70A44-0BCB-49B8-982D-8C81A51E3AA1Q40090715-7EC8A4B8-DF27-43EF-A8D9-3894A212CD97Q42366904-19067859-AA02-4229-9776-D5143970F047Q43164991-AE4822BC-1B54-4D28-B314-69F61BCFEF7AQ46205144-307F917E-F65C-4786-A6B7-D239773704DAQ47751329-CE407C91-F28C-47A8-90A4-0544EDC854CCQ48123713-5CEB1095-C46D-4D96-8B24-3494AC8299FE
P2860
Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@en
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@nl
type
label
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@en
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@nl
prefLabel
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@en
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@nl
P2860
P50
P356
P1433
P1476
Clinical impact and molecular ...... n non-baumannii Acinetobacter.
@en
P2860
P304
P356
10.2217/FMB.11.30
P577
2011-05-01T00:00:00Z